Evidence map›Paper›PMID 30980069›Full record

ReviewNature reviews. Microbiology2019

Definitions and guidelines for research on antibiotic persistence.

Nathalie Q Balaban, Sophie Helaine, Kim Lewis, Martin Ackermann, Bree Aldridge, Dan I Andersson, Mark P Brynildsen, Dirk Bumann, Andrew Camilli, James J Collins and 15 more

Erratum issued Registry-linked trialAbstract readReview
In one paragraph

Review in Nature reviews. Microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05826067 (Systematic Analysis of Bacterial Multidrug Tolerance in Longitudinal Isolates of Patients That Are Prone to Developing Urinary Tract Infections), which is not on this map. Cited by 770 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
770citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05826067 recruitingnot on this mapstarted 2023, after this paper: background citation

Systematic Analysis of Bacterial Multidrug Tolerance in Longitudinal Isolates of Patients That Are Prone to Developing Urinary Tract Infections

TypeobservationalSponsorUniversité Catholique de LouvainRan2023 to 2025Enrolled45ConditionsUrinary Tract Infections, Patients With Suprabubic Catheter, Patients With Nephrostomy CatheterArmscollection of bacterial strains
3 · Its place in the literature

Who cites it

770 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Dismantling the eDNA-mediated HBioactive materials · 2027
    Article
  4. Review
  5. Virulence · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. MakingCell insight · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

710 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Nathalie Q BalabanRacah Institute of Physics, The Hebrew University, Jerusalem, Israel. nathalie.balaban@mail.huji.ac.il.ORCID http://orcid.org/0000-0001-8018-0766
Sophie HelaineMRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-9877-4180
Kim LewisDepartment of Biology, Northeastern University, Boston, MA, USA.
Martin AckermannInstitute of Biogeochemistry and Pollutant Dynamics, ETH Zurich, Zurich, Switzerland.
Bree AldridgeDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA, USA.
Dan I AnderssonDepartment of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0001-6640-2174
Mark P BrynildsenDepartment of Chemical and Biological Engineering, Princeton University, Princeton, NJ, USA.
Dirk BumannFocal Area Infection Biology, Biozentrum of the University of Basel, Basel, Switzerland.
Andrew CamilliDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA, USA.
James J CollinsInstitute for Medical Engineering & Science, Department of Biological Engineering, and Synthetic Biology Center, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-5560-8246
Christoph DehioFocal Area Infection Biology, Biozentrum of the University of Basel, Basel, Switzerland.
Sarah FortuneDepartment of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA.ORCID http://orcid.org/0000-0001-7565-9975
Jean-Marc GhigoInstitut Pasteur, Genetics of Biofilms Laboratory, Paris, France.
Wolf-Dietrich HardtInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.
Alexander HarmsFocal Area Infection Biology, Biozentrum of the University of Basel, Basel, Switzerland.
Matthias HeinemannMolecular Systems Biology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Groningen, Netherlands.ORCID http://orcid.org/0000-0002-5512-9077
Deborah T HungBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Urs JenalFocal Area Infection Biology, Biozentrum of the University of Basel, Basel, Switzerland.
Bruce R LevinDepartment of Biology, Emory University, Atlanta, GA, USA.
Jan MichielsCenter for Microbiology, KU Leuven-University of Leuven, Leuven, Belgium.
Gisela StorzDivision of Molecular and Cellular Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, USA.
Man-Wah TanInfectious Diseases Department, Genentech, South San Francisco, CA, USA.
Tanel TensonInstitute of Technology, University of Tartu, Tartu, Estonia.
Laurence Van MelderenFaculté des Sciences, Université Libre de Bruxelles, Bruxelles, Belgium.
Annelies ZinkernagelDivision of Infectious Diseases, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Funding

Study of transmissible forms of Vibrio CholeraeR01AI055058 · NIAID · TUFTS UNIVERSITY BOSTON · PI CAMILLI, ANDREW · 2003 to 2019
$5.8M
Phage Resistance in Emergent Vibrio cholerae and Phage Prophylaxis of CholeraR37AI055058 · NIAID · TUFTS UNIVERSITY BOSTON · PI Andrew Camilli · 2020 to 2026
$3.4M
Theoretical and experimental strudy of the population and evolutionary dynamics oR01GM091875 · NIGMS · EMORY UNIVERSITY · PI LEVIN, BRUCE RICHARD · 2009 to 2017
$2.5M
Medical Research Council MR/P028225/1NIAID NIH HHS R01 AI055058NIAID NIH HHS R37 AI055058NIGMS NIH HHS R01 GM091875
6 · The paper itself

Abstract

Increasing concerns about the rising rates of antibiotic therapy failure and advances in single-cell analyses have inspired a surge of research into antibiotic persistence. Bacterial persister cells represent a subpopulation of cells that can survive intensive antibiotic treatment without being resistant. Several approaches have emerged to define and measure persistence, and it is now time to agree on the basic definition of persistence and its relation to the other mechanisms by which bacteria survive exposure to bactericidal antibiotic treatments, such as antibiotic resistance, heteroresistance or tolerance. In this Consensus Statement, we provide definitions of persistence phenomena, distinguish between triggered and spontaneous persistence and provide a guide to measuring persistence. Antibiotic persistence is not only an interesting example of non-genetic single-cell heterogeneity, it may also have a role in the failure of antibiotic treatments. Therefore, it is our hope that the guidelines outlined in this article will pave the way for better characterization of antibiotic persistence and for understanding its relevance to clinical outcomes.

Indexed as

Drug ToleranceAnti-Bacterial AgentsBacteriaBiomedical ResearchGuidelines as TopicTerminology as TopicAnti-Bacterial Agents

Identifiers

PMID30980069
PMCPMC7136161

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.